SC 13G Filing

Company

Sarepta Therapeutics, Inc.

Filed

April 1, 2005

Accession Number

0001221825-05-000034

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →